HUP0202701A2 - Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0202701A2
HUP0202701A2 HU0202701A HUP0202701A HUP0202701A2 HU P0202701 A2 HUP0202701 A2 HU P0202701A2 HU 0202701 A HU0202701 A HU 0202701A HU P0202701 A HUP0202701 A HU P0202701A HU P0202701 A2 HUP0202701 A2 HU P0202701A2
Authority
HU
Hungary
Prior art keywords
dione derivatives
optionally substituted
pharmaceutical compositions
compositions containing
substituted benzylthiazolidine
Prior art date
Application number
HU0202701A
Other languages
English (en)
Inventor
Hiroyuki Miyachi
Koji Murakami
Masahiro Nomura
Takahiro Tanase
Masaki Tsunoda
Original Assignee
Kyorin Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd. filed Critical Kyorin Pharmaceutical Co., Ltd.
Publication of HUP0202701A2 publication Critical patent/HUP0202701A2/hu
Publication of HUP0202701A3 publication Critical patent/HUP0202701A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A találmány tárgyát új (1) általános képletű szubsztituáltbenziltiazolidin-2,4-dion-származékok - a képletben A jelentése adottesetben szubsztituált fenilcsoport, adott esetben szubsztituáltfenoxicsoport vagy adott esetben szubsztituált benziloxicsoport - ésgyógyászatilag elfogadható sóik és hidrátjaik képezik, amelyekligandumként a humán peroxiszóma proliferátor-aktivált receptorhoz(PPAR) kötődve aktiválják azt, és vércukorcsökkentő hatással éslipidcsökkentő hatással rendelkeznek. Ó
HU0202701A 1999-08-23 2000-08-18 Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them HUP0202701A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23552999 1999-08-23
JP2000242707 2000-08-10
PCT/JP2000/005521 WO2001014351A1 (fr) 1999-08-23 2000-08-18 Derives de benzylthiazolidine-2,4-dione substitues

Publications (2)

Publication Number Publication Date
HUP0202701A2 true HUP0202701A2 (hu) 2002-12-28
HUP0202701A3 HUP0202701A3 (en) 2004-12-28

Family

ID=26532181

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202701A HUP0202701A3 (en) 1999-08-23 2000-08-18 Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US6734199B1 (hu)
EP (1) EP1207157B1 (hu)
KR (1) KR100700304B1 (hu)
CN (1) CN1167691C (hu)
AT (1) ATE296815T1 (hu)
AU (1) AU778721B2 (hu)
CA (1) CA2382573C (hu)
DE (1) DE60020573T2 (hu)
HU (1) HUP0202701A3 (hu)
WO (1) WO2001014351A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
US7507767B2 (en) * 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
CN1870983B (zh) * 2002-02-14 2010-12-01 麒麟麦酒株式会社 用于改善脂质代谢的组合物和食品
WO2003088962A1 (en) * 2002-04-16 2003-10-30 Merck & Co., Inc. Combination therapy using a ppar alpha/gamma agonist
KR20050068860A (ko) 2003-12-30 2005-07-05 엘지.필립스 엘시디 주식회사 듀얼 플레이트 유기전계 발광소자용 상부기판 및 그의제조방법
KR20070050475A (ko) * 2004-08-11 2007-05-15 교린 세이야꾸 가부시키 가이샤 신규 환상 아미노 안식향산 유도체
EP1862464A4 (en) * 2005-03-23 2010-08-25 Kyorin Seiyaku Kk NEW CYCLIC AMINOPHENYL ALKANIC ACID DERIVATIVE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3929512B2 (ja) * 1995-06-02 2007-06-13 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
AU2231397A (en) * 1996-03-08 1997-09-22 Torii Pharmaceutical Co., Ltd. Thiazolidine-2,4-dione derivatives
NZ314406A (en) 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
JPH09301963A (ja) * 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition

Also Published As

Publication number Publication date
KR100700304B1 (ko) 2007-03-29
AU778721B2 (en) 2004-12-16
CN1167691C (zh) 2004-09-22
EP1207157A1 (en) 2002-05-22
EP1207157A4 (en) 2002-09-18
EP1207157B1 (en) 2005-06-01
AU6594700A (en) 2001-03-19
DE60020573D1 (de) 2005-07-07
CA2382573C (en) 2007-05-22
CN1382128A (zh) 2002-11-27
CA2382573A1 (en) 2001-03-01
DE60020573T2 (de) 2006-03-16
HUP0202701A3 (en) 2004-12-28
WO2001014351A1 (fr) 2001-03-01
ATE296815T1 (de) 2005-06-15
US6734199B1 (en) 2004-05-11
KR20020022813A (ko) 2002-03-27

Similar Documents

Publication Publication Date Title
CY1124503T1 (el) Βοριοφθαλιδια για θεραπευτικη χρηση
HUP0402133A2 (hu) Szubsztituált fenil-propionsav-származékok mint a humán peroxiszóma proliferátor-aktivált receptor alfa(PPAR) agonistái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BRPI0409109A (pt) novos compostos
DK1184366T3 (da) Substituerede phenylpropionsyrederivater som agonister for human perioxisomproliferatoraktiveret receptor alpha(PPAR)
HUP0402236A2 (hu) Heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE0302760D0 (sv) New compounds
PT1213296E (pt) Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao
DK1076644T3 (da) N-Substituerede aminotetraliner som ligander for neutopeptid Y Y5-receptoren, der er nyttig til behandling af fedme og andre lidelser
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
MA29550B1 (fr) Derives de n- (pyridine-2-yl) - sulfonamide
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
PL398536A1 (pl) Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie do leczenia HIV
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
HUP0202520A2 (hu) Szubsztituált benzil-tiazolidin-2,4-dion-származékok és az azokat tartalmazó gyógyszerkészítmények
DE60110262D1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
HUP0202731A2 (hu) o-Ánizsamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JO2409B1 (en) Second-phenyl carboxy amides are useful as lipid-lowering agents
HUP0202701A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
MY133512A (en) Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors
SE0303480D0 (sv) Benzofuranes
HUP0202893A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyászati készítmények
HUP0203884A2 (hu) Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
BRPI0417946A (pt) composto, métodos para o tratamento ou a profilaxia de uma doença ou condição, e de distúrbios, e para a indução da cessação do hábito de fumar, composição farmacêutica, e, uso de um composto